Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details)

v3.21.2
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
Jul. 26, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Related Party Transaction [Line Items]            
Accounts payable due to related parties   $ 138,501   $ 138,501   $ 149,067
CEO            
Related Party Transaction [Line Items]            
Compensation amount received related to related party transaction   68,750 $ 128,750 355,000 $ 250,625  
PillTracker SOW            
Related Party Transaction [Line Items]            
Payment to related party   289,308 118,642 685,066 118,642  
Total cost under SOW $ 157,110          
Neuro Rx | Chief Commercial Officer            
Related Party Transaction [Line Items]            
Payment to related party   28,580 19,585 58,320 60,355  
Neuro Rx | Glytech Agreement            
Related Party Transaction [Line Items]            
Continuing technology support services and reimbursed expenses   $ 0 $ 0 $ 125,000 $ 82,569  
Related party transaction description       The Excluded Technology will transfer to the Company for no additional consideration if aggregate the value of NRx Pharmaceuticals equity held by Glytech exceeds $50,000,000 on any date prior to August 6, 2022, based on the average daily value of the equity held by Glytech during a period of 20 consecutive days prior to such date.